Biography
As the Director of Assay Development at Quadrant Biosciences, Dr. Wright leads his team inthe development of novel saliva-based assays in the fields of genetics, epigenetics and virology,with a primary focus on neurodevelopmental and neurodegenerative diseases and disorders.These assays will be evolutionary in the advancement of diagnostics that will aid in the earlydetection of global health priorities such as autism spectrum disorder, concussion andParkinson’s disease.These comprehensive testing solutions will utilize at-home, saliva-based sample collection, idealfor telehealth-enabled practices, and allow for increased access to much-needed patient testing.
Track Chair: Cindy Lawley, Olink